Krzysztof Kilian

Dr. Krzysztof Kilian

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in Reports of Practical Oncology and Radiotherapy
Verified
Journal Article
Closed access
KKKrzysztof Kilian
Krzysztof Kilian
The construction of the 68Ge/68Ga generator has increased application of radiopharmaceuticals labeled with this isotope in medicine. 68Ga-PET is widely employed in the management of neuroendocrine tumors but favorable chemistry with tri- and tetraaza-ring molecules has opened wide range of 68Ga application in other fields of PET imaging. This review covers the radiopharmaceuticals labeled with gallium in molecular imaging and shows perspectives on the use of gallium-68 as a substitute for technetium-99, fluorine-18 and carbon-11 in some applications.

2 January 2018 in Separation & Purification Reviews
Verified
Journal Article
Closed access
Krystyna PyrzynskaKrystyna Pyrzynska
Krystyna Pyrzynska
KKKrzysztof Kilian
Krzysztof Kilian
MPMateusz Pęgier
Mateusz Pęgier
Scandium and its compounds are used in many modern industrial fields due to its unique chemical and physical properties. It is mainly recovered from residues and wastes in the production of other metals. The exploitation of the ores and wastes could contaminate water and soil creating environmental problems. This paper discusses recent developments and tendencies in scandium separation, purification and preconcentration from different wastes, residues, environmental samples as well as in the production of radiopharmaceuticals for nuclear medicine, both in the laboratory and on the industrial scale. The period reviewed here mainly includes publications that have appeared, since 2010.

21 May 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Krystyna PyrzynskaKrystyna Pyrzynska
Krystyna Pyrzynska
KKKrzysztof Kilian
Krzysztof Kilian
MPMateusz Pęgier
Mateusz Pęgier
Porphyrin ligands, showing a significant affinity for cancer cells, also have the ability to chelate metallic radioisotopes to form potential diagnostic radiopharmaceuticals. They can be applied in single-photon emission computed tomography (SPECT) and positron emission tomography (PET) to evaluate metabolic changes in the human body for tumor diagnostics. The aim of this paper is to present a short overview of the main metallic radionuclides complexed by porphyrin ligands and used in these techniques. These chelation reactions are discussed in terms of the complexation conditions and kinetics and the complex stability.

25 March 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MFMichal Fiedorowicz
Michal Fiedorowicz
MKM. I. Khan
M. I. Khan
DSD. Strzemecki
D. Strzemecki
JOJ. Orzeł
J. Orzeł
MWM. Wełniak-Kamińska
M. Wełniak-Kamińska
Anna M. Czarnecka, MBAAnna M. Czarnecka, MBA
Anna M. Czarnecka, MBA
Clear cell renal cell carcinoma (ccRCC) is the most common kidney cancer. Prognosis for ccRCC is generally poor since it is largely resistant to chemo- and radiotherapy. Many studies suggested that cancer stem cells/tumor initiating cells (CSCs/TICs) are responsible for development of tumor, disease progression, aggressiveness, metastasis and drug resistance. However, tumorigenic potential of CSCs/TICs isolated from established RCC cell lines – basic ccRCC research model – has never been investigatedin vivo. CD105+, CD105−, CD44+ and CD44− as well as CD44−/CD105− CD44+/CD105+ and CD44−/CD105+ cells were isolated from Caki-1 RCC cell line, confirming coexistence of multiple subpopulations of stem-related phenotype in stable cell line. Sorted cells were injected subcutaneously into NOD SCID mice and tumor growth was monitored with MRI and PET/CT. Tumor growth was observed after implantation of CD105+, CD44+, CD44−, CD44−/CD105+ and CD44−/CD105− but not CD105− or CD44+/CD105+. Implantation of CD44−/CD105− cells induced tumors that were characterized by longer T1 and distinct metabolic pattern than other tumors. All the tumors were characterized by low uptake of [18F]FDG. CD105+ and CD44− tumors expresses Nanog and Oct-4, while CD44− tumors additionally expressed endothelial cell marker - CD31.

20 July 2018 in Molecules
Verified
Journal Article
Open access
PDF file
KKKrzysztof Kilian
Krzysztof Kilian
LCLukasz Cheda
Lukasz Cheda
MSMateusz Sitarz
Mateusz Sitarz
KSKatarzyna Szkliniarz
Katarzyna Szkliniarz
JCJarosław Choiński
Jarosław Choiński
ASAnna Stolarz
Anna Stolarz
The rapid increase in applications of scandium isotopes in nuclear medicine requires new efficient production routes for these radioisotopes. Recently, irradiations of calcium in cyclotrons by α, deuteron, and proton beams have been used. Therefore, effective post-irradiation separation and preconcentration of the radioactive scandium from the calcium matrix are important to obtain the pure final product in a relatively small volume. Nobias resin was used as a sorbent for effective separation of 44Sc from calcium targets. Separation was performed at pH 3 using a column containing 10 mg of resin. Scandium was eluted with 100 μL of 2 mol L−1 HCl. Particular attention was paid to the reduction of calcium concentration, presence of metallic impurities, robustness and simple automation. 44Sc was separated with 94.9 ± 2.8% yield, with results in the range of 91.7–99.0%. Purity of the eluate was confirmed with ICP-OES determination of metallic impurities and >99% chelation efficiency with DOTATATE, followed by >36 h radiochemical stability of the complex. A wide range of optimal conditions and robustness to target variability and suspended matter facilitates the proposed method in automatic systems for scandium isotope separation and synthesis of scandium-labeled radiopharmaceuticals.

25 August 2017 in Solvent Extraction and Ion Exchange
Verified
Journal Article
Closed access
KKKrzysztof Kilian
Krzysztof Kilian
Krystyna PyrzynskaKrystyna Pyrzynska
Krystyna Pyrzynska
MPMateusz Pęgier
Mateusz Pęgier
The sorption behavior of Sc(III) on different materials including activated carbon (AC), carbon nanotubes (CNTs), graphene oxide (GO), and the chelating resin Chelex 100 was investigated. In general, the sorption of scandium increases with increasing pH. For pH in the range from 2.5 to 5.5, the sorption of Sc(III) onto CNTs, GO, and Chelex 100 is quantitative, whereas a significantly lower amount of scandium ions was retained on AC. The specific amount of Sc(III) adsorbed at pH 2 attained 2.1, 2.9, 36.5, and 37.9 mg g−1 for AC-COOH, Chelex 100, GO, and CNTs-COOH, respectively. At pH 4, a similar value was obtained for oxidized AC (2.2 mg g−1), whereas the specific amount adsorbed significantly increased for Chelex (23.4 mg g−1). The highest values were obtained for GO (39.7 mg g−1) and oxidized CNTs (42.5 mg g−1). Better kinetic retention was observed at pH 2 for CNTs and GO, whereas at pH 4 the kinetic behavior of Chelex 100, GO, and CNTs toward Sc(III) was comparable.